Sales and Marketing

Showing 15 posts of 11524 posts found.

Novartis boasts strong sales for 2008

February 11, 2009 Sales and Marketing Novartis

Novartis has weathered the financial downturn and delivered a strong performance for 2008. Overall group sales were boosted by 9% …

Health secretary to chair influential pharma group

February 11, 2009 Sales and Marketing ABPI, reform

Health Secretary Alan Johnson has been appointed the chair of the Ministerial Industry Strategy Group (MISG) and business secretary Lord …

Industry braced for more mergers

February 11, 2009 Sales and Marketing MA, restructure

In retrospect, Pfizer's move to buy another major pharmaceutical company was inevitable. Like its peers, Pfizer has been energetically restructuring …

Roche hit by strong Swiss franc

February 10, 2009 Sales and Marketing Roche

Roche delivered solid performance in 2008, but was unable to shake off the negative effect of a strong Swiss franc. …

Roche bid for Genentech turns ‘hostile’ – but stays friendly

February 10, 2009 Sales and Marketing MA, Roche

Roche has launched a renewed bid to buy out Genentech, making a 'hostile' bid for the company by appealing directly …

GSK expands cost cutting drive

February 9, 2009 Sales and Marketing GSK, restructure

GlaxoSmithKline has expanded its restructuring plans and will make widespread job cuts in a bid to cut costs throughout its …

India’s Piramal at centre of buy-out speculation

February 9, 2009 Sales and Marketing MA, Piramal

Indian pharmaceutical company Piramal has denied that it ready to sell up to one of the global giants of the …

Job losses mounting at smaller drugmakers

February 5, 2009 Sales and Marketing restructure

Another week, and another swathe of job losses across the pharmaceutical sector, with sales and back office staff once again …

What are pharma’s core competencies?

February 5, 2009 Research and Development, Sales and Marketing pharma, strategy

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …

NICE approves Sutent but rejects rivals

February 4, 2009 Sales and Marketing NICE, par

NICE has approved Pfizer's Sutent but rejected three other treatments for kidney cancer. The decision is one of the first …

The Brand MOT

February 3, 2009 Sales and Marketing branding, marketing

To have a car on the road once it's more than three years old requires an MOT – an annual …

Evidence HRT could reduce bowel cancer risk

February 2, 2009 Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …

The Pfizer-Wyeth merger

February 2, 2009 Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …

AstraZeneca to cut more jobs as sales stagnate

January 30, 2009 Sales and Marketing AZ, restructure

AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …

Crucell linked with new takeover suitors

January 29, 2009 Sales and Marketing Crucell, MA

Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …
The Gateway to Local Adoption Series

Latest content